Literature DB >> 6858843

Pulmonary hypertension in isolated secundum atrial septal defect: high frequency in young patients.

G Cherian, C B Uthaman, M Durairaj, I P Sukumar, S Krishnaswami, P S Jairaj, S John, H Krishnaswami, A Bhaktaviziam.   

Abstract

Out of 709 consecutive patients with isolated secundum atrial septal defect, the pulmonary artery systolic pressure was greater than 50 mm Hg in 118 patients (17%). Pulmonary hypertension was present in 13% of patients under 10 years and in 14% aged 11 to 20 years. The Eisenmenger reaction was present in 9% of the 709 patients. The frequency of the Eisenmenger reaction was high in young patients and was not significantly different in patients in the first and second decades as compared to older patients. None of our patients with pulmonary hypertension resided at high altitude. The high frequency of pulmonary hypertension in our young patients cannot be satisfactorily explained. Autopsy studies suggest that in some, pulmonary hypertension is due to the persistence of the fetal pulmonary vascular pattern.

Entities:  

Mesh:

Year:  1983        PMID: 6858843     DOI: 10.1016/0002-8703(83)90396-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

Review 1.  Pulmonary hypertension complicating congenital heart disease.

Authors:  J Eduardo Rame
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

2.  Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects.

Authors:  M Vogel; F Berger; A Kramer; V Alexi-Meshkishvili; P E Lange
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

Review 3.  Clinical presentations of unoperated and operated adults with congenital heart disease.

Authors:  Christopher R Ellis; Thomas P Graham; Benjamin F Byrd
Journal:  Curr Cardiol Rep       Date:  2005-07       Impact factor: 2.931

4.  Pulmonary vascular disease in a child with atrial septal defect of the secundum type and type I glycogen storage disease.

Authors:  D Bolz; F Stocker; A Zimmermann
Journal:  Pediatr Cardiol       Date:  1996 Jul-Aug       Impact factor: 1.655

5.  Benefit of atrial septal defect closure in adults: impact of age.

Authors:  Michael Humenberger; Raphael Rosenhek; Harald Gabriel; Florian Rader; Maria Heger; Ursula Klaar; Thomas Binder; Peter Probst; Georg Heinze; Gerald Maurer; Helmut Baumgartner
Journal:  Eur Heart J       Date:  2010-10-12       Impact factor: 29.983

6.  Long-term outcome after surgical closure of atrial septal defect in childhood with extensive assessment including MRI measurement of the ventricles.

Authors:  D Bolz; T Lacina; P Buser; M Buser; J Guenthard
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

7.  Pulmonary blood flow and pulmonary hypertension: Is the pulmonary circulation flowophobic or flowophilic?

Authors:  Thomas J Kulik
Journal:  Pulm Circ       Date:  2012-07       Impact factor: 3.017

8.  Transient use of oral bosentan can be an additional option to reduce pulmonary arterial hypertension in a patient with severe pulmonary arterial hypertension associated with atrial septal defect.

Authors:  Yong Kyu Park; Jae-Hyeong Park; Jae Hyeon Yu; Jun Hyung Kim; Jae-Hwan Lee; Si Wan Choi; Jin-Ok Jeong; In-Whan Seong
Journal:  J Cardiovasc Ultrasound       Date:  2011-09-30

9.  Challenges in Device Closure of Secundum Atrial Septal Defect in Older Patients in Their Fifth Decade and Beyond.

Authors:  Anil K Singhi; Soumya K Mahapatra; Dilip Kumar; Somnath Dey; Amiya Mishra; Arnab De
Journal:  Cureus       Date:  2022-02-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.